Loading clinical trials...

A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT01421472

A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

To demonstrate whether addition of MM-121 to paclitaxel is more effective than treatment with paclitaxel alone, when administered as part of the neoadjuvant treatment in Her2 negative locally advanced...

Lead sponsor: Merrimack Pharmaceuticals•38 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 2

Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen

NCT03304756 · Triple Negative Breast Cancer Patients

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 3, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment196

Start dateAug 2011

Last updatedMay 3, 2016

Condition

ER Positive, Her2 Negative Breast Cancer Patients Triple Negative Breast Cancer Patients

Locations shown

Universito of Birmingham atAlabama

Birmingham, Alabama

Arizona Oncology Associates

Tucson, Arizona

Arizona Oncology Associates

Tuscon, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 3, 2016Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions